ArticlePharmaceutics2022

CD44-Receptor Targeted Gold-Doxorubicin Nanocomposite for Pulsatile Chemo-Photothermal Therapy of Triple-Negative Breast Cancer Cells.

Dnyaneshwar Kalyane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.